Thiamine Hcl Injection, Solution
Product Images NDC 51662-1523

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Thiamine Hcl (NDC 51662-1523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Description)

Chemical structure of Thiamine HCl, showing its fused thiazole and pyrimidine rings, various methyl, amino, hydroxyl, and ethyl substituents, and chloride and hydrochloride groups.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Label (Serialized Vial Labeling)

Thiamine HCl Injection, USP in a 2 mL amber glass multiple dose vial with a blue cap. The label indicates a strength of 200 mg per 2 mL (100 mg per mL) for intramuscular or intravenous use. The vial is labeled with NDC 63323-013-01 and includes usage instructions and storage information.*

FDA Label Image

V1 (Vial Labeling)

Label for THIAMINE HCl Injection, USP 200 mg/2 mL (100 mg/mL) sterile solution for intramuscular or intravenous use. It is a 2 mL multiple dose vial, Rx only, labeled by HF Acquisition Co LLC, DBA HealthFirst. The label includes dosage instructions and storage conditions, with a caution to protect from light.*

FDA Label Image

V2 (Vial Labeling P 2)

Label for Thiamine HCl Injection, USP, 200 mg per 2 mL (100 mg per mL) solution for injection. The vial is a multiple-dose 2 mL injectable for intramuscular or intravenous use. The label shows the NDC 63323-013-01 and is manufactured by Fresenius Kabi.*

FDA Label Image

Vial Label (1523 2 Vial)

Label for Thiamine HCl Injection, USP showing 200 mg per 2 mL (100 mg per mL) strength in a 2 mL multiple dose vial. Label indicates intramuscular or intravenous use and includes manufacturer Fresenius Kabi. Includes barcode, lot/expiration placeholder, and protective instructions.*

FDA Label Image

Pouch Labeling (1523 2 Pouch)

Label for THIAMINE HCl Injection, USP 200 mg/2 mL (100 mg/mL) vial. The label indicates intramuscular or intravenous use, sterile solution with active ingredient thiamine HCl 100 mg/mL and additional excipients. Manufactured by HF Acquisition Co LLC, Mukilteo, WA. Includes NDC 51662-1523-2 and lot number and expiration date fields. Contains storage instructions and manufacturer details.*

FDA Label Image

Case (1523 3 Case)

Label for THIAMINE HCl Injection, USP 200 mg/2 mL (100 mg/mL) in a 2 mL vial, packaged as a case of 25. The label indicates intramuscular and intravenous use, manufacturer HF Acquisition Co LLC, and includes NDC 51662-1523. The label features lot and expiration date information, storage instructions, and usage details.*

FDA Label Image

Rfid Label (51662 1523 3 Rfid)

Label for THIAMINE HCl injection, solution, 100 mg/mL, distributed by HF Acquisitions Co., LLC, Mukilteo, WA. The label includes a barcode and various identification numbers, along with instructions to see the manufacturer's insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.